RATIONAL FOR THE USE OF COCONUT OIL-BASED ANTI-MYCOTIC PESSARIES TO COMBAT RECURRENT VAGINAL INFECTION: IN-VITRO/IN-VIVO EVALUATION AND PRELIMINARY PROSPECTIVE CLINICAL INVESTIGATION


Rabab Kamel, Haidy Abbas

Abstract


Objective: Coconut oil (CO) was used in combination with metronidazole in order to prepare vaginal pessaries ameliorating the use, delivery and efficacy of the anti-mycotic treatment.

Methods: To prepare the metronidazole–loaded pessaries, different lipids, namely: suppocire NA15 (SNA), suppocire NAIS10 (SIS), suppocire AM (SAM) and ovucire WL 2944 (OWL) were used alone or in combination with coconut oil in a ratio of 1:1. Prepared pessaries were subjected to characterization and evaluation of physical properties, drug release, anti-microbial effect, in-vivo studies and histopathological examination.

Results: In the case of all the lipids, coconut oil improved the physical properties which can allow better use and performance of the pessaries. Among the prepared pessaries, the OWL/CO-based pessary (P8) showed the highest drug release profile (P<0.05).   Characterization was done using X-Ray diffraction. Microbiological study showed the superiority of OWL/CO-based pessaries over OWL-based pessaries at different time intervals. Histopathological studies of the vagina of female Wistar rats showed that in the case of the Candida albicans-infected group treated with the selected pessary, the mucosal and muscular layer returned to its normal structure, in addition to the disappearance of the cauliflower-like projections and the newly formed blood capillaries, seen in the Candida albicans-infected group.  The questionnaire done in volunteers suffering from recurrent vaginal infection reported a significant decrease (reaching 93 %) in the severity of the symptoms, after the use of the suggested pessaries (P8) (P<0.05).  Also, the suggested product had a high patient acceptability. The results reported after the use of P8 were better than those of Amrizole® vaginal suppository.  

Conclusion: The current study can present a successful, effective and easy to use product with low cost and minimal side effects.


References


Horowitz, B.J., Giaquinta, D., and Ito, S. Evolving pathogens in vulvovaginal candidiasis: implications for patient care. J Clin Pharmacol 1992; 32: p. 248-55.

Dolzhykova, O., Maloshtan, L., Yeriomenko, R., and Maloshtan, V. Effect of the vaginal pessaries Melanizol® and Klimedeks® on the glycogen level in the vaginal tissue of rats on the background of experimental vaginitis. Ceska a Slovenska farmacie: casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti 2017; 66: p. 117-26.

Kamel, R. and Abbas, H. A multi-microcarrier of Metronidazole-biopolymers complexes as a potential vaginal delivery system. International Journal of Polymeric Materials and Polymeric Biomaterials 2018; 67: p. 236-45.

Bradshaw, C.S., Morton, A.N., Hocking, J., Garland, S.M., Morris, M.B., Moss, L.M., et al. High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence. The Journal of infectious diseases 2006; 193: p. 1478-86.

Sobel, J.D., Wiesenfeld, H.C., Martens, M., Danna, P., Hooton, T.M., Rompalo, A., et al. Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis. New England Journal of Medicine 2004; 351: p. 876-83.

Kamel, R. Study of the influence of selected variables on the preparation of prolonged release bioadhesive vaginal carbohydrate microspheres using experimental design. J Drug Deliv Sci Tech 2013; 23: p. 247-54.

Khattab, A. and Ismail, S. Formulation and evaluation of oxiconazole nitrate mucoadhesive nanoemulsion based gel for treatment of fungal vaginal infection. Int j Pharm Pharm Sci 2016; 8: p. 33-40.

Tsai, M.L., Lin, C.C., Lin, W.C., and Yang, C.H. Antimicrobial, antioxidant, and anti-inflammatory activities of essential oils from five selected herbs. Biosci Biotechnol Biochem 2011; 75: p. 1977-83.

Kamel, R., Abbas, H., and Fayez, A. Diosmin/essential oil combination for dermal photo-protection using a lipoid colloidal carrier. J Photochem Photobiol B 2017; 170: p. 49-57.

Sivapriya, V., Ponnarmadha, S., Azeezand, N.A., and Sudarshanadeepa, V. Novel nanocarriers for ethnopharmacological formulations. Int J app Pham 2018; 10: p. 26-30.

Santos, S.S., Lorenzoni, A., Pegoraro, N.S., Denardi, L.B., Alves, S.H., Schaffazick, S.R., et al. Formulation and in vitro evaluation of coconut oil-core cationic nanocapsules intended for vaginal delivery of clotrimazole. Colloids Surf B Biointerfaces 2014; 116: p. 270-6.

Kabara, J.J., Swieczkowski, D.M., Conley, A.J., and Truant, J.P. Fatty acids and derivatives as antimicrobial agents. Antimicrobial agents and chemotherapy 1972; 2: p. 23-8.

Skřivanová, E., Marounek, M., Benda, V., and Březina, P. Susceptibility of Escherichia coli, Salmonella sp and Clostridium perfringens to organic acids and monolaurin. Veterinární medicína 2006.

Bergsson, G., Steingrímsson, Ó., and Thormar, H. In vitro susceptibilities of Neisseria gonorrhoeae to fatty acids and monoglycerides. Antimicrobial agents and chemotherapy 1999; 43: p. 2790-2.

Ogbolu, D.O., Oni, A.A., Daini, O.A., and Oloko, A. In vitro antimicrobial properties of coconut oil on Candida species in Ibadan, Nigeria. Journal of medicinal food 2007; 10: p. 384-7.

Marina, A., Man, Y.C., Nazimah, S., and Amin, I. Chemical properties of virgin coconut oil. Journal of the American Oil Chemists' Society 2009; 86: p. 301-7.

Bergsson, G., Arnfinnsson, J., Steingrı́msson, Ó., and Thormar, H. In vitro killing of Candida albicans by fatty acids and monoglycerides. Antimicrobial agents and chemotherapy 2001; 45: p. 3209-12.

Lard-Whiteford, S.L., Matecka, D., O'Rear, J.J., Yuen, I.S., Litterst, C., and Reichelderfer, P. Recommendations for the nonclinical development of topical microbicides for prevention of HIV transmission: an update. J Acquir Immune Defic Syndr 2004; 36: p. 541-52.

Belniak, P., Świąder, K., Szumiło, M., Hyla, A., and Poleszak, E. Comparison of physicochemical properties of suppositories containing starch hydrolysates. Saudi Pharmaceutical Journal 2017; 25: p. 365-9.

in British Pharmacopoeia1993: London. p. 159-60.

Abass, H., Kamel, R., and Abdelbary, A. Metronidazole bioadhesive vaginal suppositories: formulation, in vitro and in vivo evaluation. Int J Pharm Pharm Sci 2012; 4: p. 344-55.

Kamel, R. and Abbas, H. PLGA-based monolithic filaments prepared by hot-melt extrusion: In-vitro comparative study. Annales Pharmaceutiques Françaises 2018; 76: p. 97-106.

Varshosaz, J., Tavakoli, N., and Kheirolahi, F. Use of hydrophilic natural gums in formulation of sustained-release matrix tablets of tramadol hydrochloride. AAPS PharmSciTech 2006; 7: p. E24.

Kamel, R. and Abbas, H.A. Self-assembled carbohydrate hydrogels for prolonged pain management. Pharm Dev Technol 2013; 18: p. 990-1004.

Liu, Y., Zhang, X., Liu, Y., Jin, X., Fan, C., Ye, H., et al. Bi-functionalization of a calcium phosphate-coated titanium surface with slow-release simvastatin and metronidazole to provide antibacterial activities and pro-osteodifferentiation capabilities. PloS one 2014; 9: p. e97741.

Perioli, L., Ambrogi, V., Pagano, C., Scuota, S., and Rossi, C. FG90 chitosan as a new polymer for metronidazole mucoadhesive tablets for vaginal administration. Int J Pharm 2009; 377: p. 120-7.

Joseph, M., Al-Hakami, A., Assiry, M., Jamil, A., Assiry, A., Shaker, M., et al. In vitro anti-yeast activity of chloramphenicol: A preliminary report. Journal de mycologie medicale 2015; 25: p. 17-22.

De Bernardis, F., Lorenzini, R., and Cassone, A., Chapter 89 - Rat Model of Candida Vaginal Infection A2 - Zak, Oto, in Handbook of Animal Models of Infection, M.A. Sande, Editor 1999, Academic Press: London. p. 735-40.

Woodsong, C. and Holt, J.D.S. Acceptability and preferences for vaginal dosage forms intended for prevention of HIV or HIV and pregnancy. Advanced Drug Delivery Reviews 2015; 92: p. 146-54.

Bergren, M.S., Battle, M.M., Halsteadt, G.W., and Theis, D.L. Investigation of the relationship between melting-related parameters and in vitro drug release from vaginal suppositories. Journal of Pharmaceutical and Biomedical Analysis 1989; 7: p. 549-61.

Kamel, R. and Mostafa, D.M. Rutin nanostructured lipid cosmeceutical preparation with sun protective potential. J Photochem Photobiol B 2015; 153: p. 59-66.




Fatal error: Call to a member function getGalleyLabel() on null in /home/innowar1/public_html/journals/cache/t_compile/%%38^38D^38D7420B%%article.tpl.php on line 182